Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Early initiation of dapagliflozin in acute decompensated heart failure does not improve diuretic efficiency

Early initiation of the sodium glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in hospitalized patients with acute decompensated heart failure (ADHF), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

The potential of targeting mitochondria-associated programmed cell death for age-related disease treatment

The review summarized the involvement of mitochondria in age-related disease progression and highlighted its potential as a therapeutic target of these diseases.

28 Aug 2023

UAB researchers show beneficial effect of verapamil for patients with Type 1 diabetes

In 2012, University of Alabama at Birmingham researcher Anath Shalev, M.D., reported that a decades-old blood pressure medication called verapamil completely reversed diabetes in animal models.

25 Aug 2023

New insights into the pathogenic mechanisms of SLC29A3 disorders

In humans, the SLC29A3 gene regulates the function of lysosomes to control waste recycling in cells such as macrophages (that engulf and destroy foreign bodies).

22 Aug 2023

A new Medicare proposal would cover training for family caregivers

Even with extensive caregiving experience, Patti LaFleur was unprepared for the crisis that hit in April 2021, when her mother, Linda LaTurner, fell out of a chair and broke her hip.

18 Aug 2023

Male diabetics more likely to have lower limb amputation

New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October) shows that among people with type 1 and type 2 diabetes, being divorced is associated with a two-thirds higher risk of lower limb amputation (LLA) (amputations below the knee level) compared with being married, and being male is associated with a 57% higher risk of LLA compared with being female. The study is by Dr Stefan Jansson, Örebro University, Örebro, Sweden, and colleagues.

18 Aug 2023

Medications for chronic diseases can impair thermoregulation, especially in hot weather

Medications to treat various chronic diseases may hinder the body’s ability to lose heat and regulate its core temperature to optimal levels.

17 Aug 2023

Study shows COVID-19 vaccination reduces, but does not entirely ameliorate, excess diabetes incidence after COVID-19

Researchers investigate the effect of COVID-19 and its vaccination on the incidence and persistence of type 2 diabetes.

15 Aug 2023

Men and women with elevated blood sugar levels have greater risk of cardiovascular diseases

Men and women with raised blood sugar levels have 30-50% greater risk of developing cardiovascular diseases even when these levels are below the threshold for diabetes, a new study has shown.

10 Aug 2023

C-Path and Sanofi collaborate to advance Type 1 Diabetes research

Critical Path Institute (C-Path) announced today that Sanofi, a global leader in immunology and diabetes care, has joined its Type 1 Diabetes Consortium (T1DC). Sanofi joins T1DC as part of its commitment to push the boundaries of innovation to improve the lives of those with diabetes.

9 Aug 2023

Study offers deeper understanding of regulatory T cells yielding therapeutic benefits

Decades of research have left knowledge gaps about cells that regulate the immune system: Purdue and NIH.

1 Aug 2023

Boston College researcher receives grant to study role of gut microbes in Type 1 diabetes

Boston College Assistant Professor of Biology Emrah Altindis has received a two-year, $275,000-grant from the Beatson Foundation to explore the role of gut microbes and viruses triggering the autoimmunity of Type 1 diabetes.

1 Aug 2023

The long-term effects of SARS-CoV-2 infection on T cell activation: autoimmune disorders and endothelial cell dysfunction

Authors explored the impact of SARS-CoV-2 on thymus (T) cell activation.

1 Aug 2023

How effective is physical activity in alleviating obesity-related inflammation in diabetes?

Scientists determine whether physical activity can be used as an effective intervention to mitigate obesity-related inflammation in diabetes.

1 Aug 2023

The incidence of diabetes following mRNA, inactivated COVID-19 vaccines, and after SARS-CoV-2 infection

Researchers evaluate the risk of new-onset diabetes linked with COVID-19 vaccination and infection.

31 Jul 2023

Researchers seek to understand the Achilles' heel of insulin pump technology

Since the insulin pump started widespread use in the early 1980s, it's become the option of choice for type 1 diabetes patients to manage their glucose levels in a way that doesn't require testing their blood sugar and injecting insulin multiple times daily.

27 Jul 2023

T cells can be used to identify type 1 diabetes risk, study shows

Scripps Research scientists have shown that analyzing a certain type of immune cell in the blood can help identify people at risk of developing type 1 diabetes, a life-threatening autoimmune disease.

19 Jul 2023

Study provides new insights into how SARS-CoV-2 affects glucose metabolism

Research conducted at the University of São Paulo (USP) in Brazil shows that SARS-CoV-2, the virus that causes COVID-19, can infect liver cells (hepatocytes), stimulating glucose production and leading to a condition similar to diabetes (hyperglycemia) in hospitalized patients, even if their blood sugar level was normal before they were admitted to hospital.

19 Jul 2023

Global burden of diabetes: new study reveals alarming prevalence and projections for 2050

Comprehensive estimates of diabetes prevalence and burden worldwide.

18 Jul 2023

What effect does honey have on human health?

Researchers reviewed existing data on the beneficial impact of honey consumption on human health.

12 Jul 2023

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Early initiation of dapagliflozin in acute decompensated heart failure does not improve diuretic efficiency

The potential of targeting mitochondria-associated programmed cell death for age-related disease treatment

UAB researchers show beneficial effect of verapamil for patients with Type 1 diabetes

New insights into the pathogenic mechanisms of SLC29A3 disorders

A new Medicare proposal would cover training for family caregivers

Male diabetics more likely to have lower limb amputation

Medications for chronic diseases can impair thermoregulation, especially in hot weather

Study shows COVID-19 vaccination reduces, but does not entirely ameliorate, excess diabetes incidence after COVID-19

Men and women with elevated blood sugar levels have greater risk of cardiovascular diseases

C-Path and Sanofi collaborate to advance Type 1 Diabetes research

Study offers deeper understanding of regulatory T cells yielding therapeutic benefits

Boston College researcher receives grant to study role of gut microbes in Type 1 diabetes

The long-term effects of SARS-CoV-2 infection on T cell activation: autoimmune disorders and endothelial cell dysfunction

How effective is physical activity in alleviating obesity-related inflammation in diabetes?

The incidence of diabetes following mRNA, inactivated COVID-19 vaccines, and after SARS-CoV-2 infection

Researchers seek to understand the Achilles' heel of insulin pump technology

T cells can be used to identify type 1 diabetes risk, study shows

Study provides new insights into how SARS-CoV-2 affects glucose metabolism

Global burden of diabetes: new study reveals alarming prevalence and projections for 2050

What effect does honey have on human health?

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in